Yalcin S - Search Results

1

The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors.

Guven DC, Ozbek DA, Sahin TK, Kavgaci G, Aksun MS, Erul E, Yildirim HC, Chalabiyev E, Cebroyilov C, Yildirim T, Dizdar O, Aksoy S, Yalcin S, Kilickap S, Erman M, Arici M. Guven DC, et al. Among authors: yalcin s. Anticancer Drugs. 2023 Jul 1;34(6):783-790. doi: 10.1097/CAD.0000000000001463. Epub 2022 Dec 19. Anticancer Drugs. 2023. PMID: 36729111

2

Leptomeningeal infiltration of malignant mesothelioma.

Oksüzoğlu B, Yalçin S, Erman M, Dağdelen S. Oksüzoğlu B, et al. Among authors: yalcin s. Med Oncol. 2002;19(3):167-9. doi: 10.1385/MO:19:3:167. Med Oncol. 2002. PMID: 12482127

3

Reactivation of hepatitis B virus infection in pancreatic cancer: a case report.

Oksüzoğlu B, Kiliçkap S, Yalcin S. Oksüzoğlu B, et al. Among authors: yalcin s. Jpn J Clin Oncol. 2002 Dec;32(12):543-5. doi: 10.1093/jjco/hyf113. Jpn J Clin Oncol. 2002. PMID: 12578904

4

Laryngeal Involvement of Rhabdomyosarcoma in an Adult.

Abali H, Aksoy S, Sungur A, Yalçin S. Abali H, et al. Among authors: yalcin s. World J Surg Oncol. 2003 Sep 17;1(1):17. doi: 10.1186/1477-7819-1-17. World J Surg Oncol. 2003. PMID: 14556654 Free PMC article.

5

Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.

Altundag K, Aksoy S, Gullu I, Altundag O, Ozyar E, Yalcin S, Cengiz M, Akyol F. Altundag K, et al. Among authors: yalcin s. Med Oncol. 2004;21(3):211-5. doi: 10.1385/MO:21:3:211. Med Oncol. 2004. PMID: 15456947

6

Orbital metastasis from adenocarcinoma of the colon.

Dizdar O, Aksoy S, Kilickap S, Yalçin S. Dizdar O, et al. Among authors: yalcin s. South Med J. 2005 Aug;98(8):846-7. doi: 10.1097/01.smj.0000168131.61080.1c. South Med J. 2005. PMID: 16144193 No abstract available.

7

Cutaneous metastases of signet cell carcinoma of the rectum without accompanying visceral involvement.

Kilickap S, Aksoy S, Dinçer M, Saglam EA, Yalçin S. Kilickap S, et al. Among authors: yalcin s. South Med J. 2006 Oct;99(10):1137-9. doi: 10.1097/01.smj.0000221633.71021.ac. South Med J. 2006. PMID: 17100038

8

Determination of circulating tumor cells for detection of colorectal cancer progression or recurrence.

Yalcin S, Kilickap S, Portakal O, Arslan C, Hascelik G, Kutluk T. Yalcin S, et al. Hepatogastroenterology. 2010 Nov-Dec;57(104):1395-8. Hepatogastroenterology. 2010. PMID: 21443092

9

Gastric cancer after cadaveric liver transplantation in a patient with autoimmune hepatitis: A case report and review of the literature.

Arslan C, Kiliçkap S, Yalçin S. Arslan C, et al. Among authors: yalcin s. Turk J Gastroenterol. 2011 Feb;22(1):73-6. doi: 10.4318/tjg.2011.0160. Turk J Gastroenterol. 2011. PMID: 21480115 Free article. Review.

10

The first line systemic chemotherapy in metastatic gastric carcinoma: A comparison of docetaxel, cisplatin and fluorouracil (DCF) versus cisplatin and fluorouracil (CF); versus epirubicin, cisplatin and fluorouracil (ECF) regimens in clinical setting.

Kilickap S, Yalcin S, Ates O, Tekuzman G. Kilickap S, et al. Among authors: yalcin s. Hepatogastroenterology. 2011 Jan-Feb;58(105):208-12. Hepatogastroenterology. 2011. PMID: 21510316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,135 results

Search Page

Filters